We're thrilled to announce that ATRI's own Robert Rissman, PhD has been awarded the prestigious 2024 Alzheimer Award from the Journal of Alzheimer's Disease (JAD). This award recognizes outstanding contributions to the advancement of AD research published in the JAD. Dr. Rissman's paper, "Evaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer's Disease," explores the potential of using a simple blood test to detect amyloid plaques in the brain, a hallmark of Alzheimer's disease.
Current methods for diagnosing AD can be expensive, invasive, and not readily available. This makes it difficult to identify people in the early stages of the disease, when interventions might be most effective. Blood tests, on the other hand, are a much more accessible option. This could be a game-changer for early detection, particularly for underserved communities. We at ATRI are incredibly proud of Dr. Rissman's achievement and excited about the potential impact of this research.